Patents by Inventor August J. Sick

August J. Sick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 7511129
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: March 31, 2009
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 7138568
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: November 21, 2006
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Novel Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Publication number: 20040194165
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Application
    Filed: April 16, 2004
    Publication date: September 30, 2004
    Applicant: Mycogen Corporation
    Inventors: Jewel Pavne, August J. Sick
  • Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 6737273
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: May 18, 2004
    Assignee: Myocogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • NOVEL BACILLUS THURINGIENSIS ISOLATE ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING NOVEL LEPIDOPTERAN-ACTIVE TOXINS
    Publication number: 20040058860
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Application
    Filed: April 19, 2001
    Publication date: March 25, 2004
    Inventors: Jewel Payne, August J. Sick
  • Bacillus thuringiensis isolated active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 6573240
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: June 3, 2003
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 6096708
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: August 1, 2000
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Protein toxins active against lepidopteran pests
    Patent number: 5985267
    Abstract: Disclosed and claimed are novel Bacillus thuringiensis isolates which have lepidopteran activity. Thus, these isolates, or mutants thereof, can be used to control such insect pests. Further, genes encoding novel .delta.-endotoxins can be removed from the isolates and transferred to other host microbes, or plants. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: November 16, 1999
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Kenneth E. Narva, H. Ernest Schnepf, George E. Schwab
  • Bacillus thuringiensis isolate active against lepidopteran pests
    Patent number: 5691308
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: November 25, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Protein toxins active against lepidopteran pests
    Patent number: 5686069
    Abstract: Disclosed and claimed are novel Bacillus thuringiensis isolates which have lepidopteran activity. Thus, these isolates, or mutants thereof, can be used to control such insect pests. Further, genes encoding novel .delta.-endotoxins can be removed from the isolates and transferred to other host microbes, or plants. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: November 11, 1997
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Kenneth E. Narva, H. Ernest Schnepf, George E. Schwab
  • Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
    Patent number: 5521286
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: May 28, 1996
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Coleopteran-active Bacillus thuringiensis toxin
    Patent number: 5457179
    Abstract: The subject invention concerns a novel microbe and gene encoding a novel toxin protein with activity against insect pests of the order Coleoptera. Pests in the order Coleoptera do heavy damage to crops, e.g., corn. The novel Bacillus thuringiensis microbe of the invention is referred to as B.t. PS50C. The spores or crystals of this microbe, or mutants thereof, are useful to control coleopteran pests in various environments. The novel gene of the invention can be used to transform various hosts wherein the novel toxic protein can be expressed.
    Type: Grant
    Filed: December 29, 1993
    Date of Patent: October 10, 1995
    Assignee: Mycogen Corporation
    Inventors: Luis Foncerrada, August J. Sick, Jewel M. Payne
  • Probes for the identification of Bacillus thuringiensis endotoxin genes
    Patent number: 5430137
    Abstract: This invention concerns novel gene probes which can be used to identify DNA from Bacillus thuringiensis microbes which encode protein endotoxins. The invention probes greatly facilitate the search for useful microbes hosting genes which encode toxins.
    Type: Grant
    Filed: October 30, 1992
    Date of Patent: July 4, 1995
    Assignee: Mycogen Corporation
    Inventors: Frank H. Gaertner, August J. Sick, Mark Thompson, H. Ernest Schnepf, George E. Schwab, Kenneth E. Narva
  • PS176 gene encoding nematode-active toxin cloned from a bacillus thuringiensis isolate
    Patent number: 5426049
    Abstract: Nematicidal .delta.-endotoxin encoding genes have been cloned from a novel Bacillus thuringiensis isolate known as B.t. PS17. These novel genes, designated B.t. PS17a, B.t. PS17b, B.t. PS17d, and B.t. PS17e, can be transferred to various microbial and plant hosts via known techniques. In the microbial or plant host, one or more of the genes of the invention can be used to express the novel nematicidal toxins to control susceptible nematodes.
    Type: Grant
    Filed: October 6, 1993
    Date of Patent: June 20, 1995
    Assignee: Mycogen Corporation
    Inventors: August J. Sick, George E. Schwab, Jewel M. Payne
  • Bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
    Patent number: 5407825
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: April 18, 1995
    Assignee: Mycogen Corp.
    Inventors: Jewel Payne, August J. Sick
  • Gene encoding a coleopteran-active toxin
    Patent number: 5366892
    Abstract: The subject invention concerns a novel microbe and gene encoding a novel toxin protein with activity against insect pests of the order Coleoptera. Pests in the order Coleoptera do heavy damage to crops, e.g., corn. The novel Bacillus thuringiensis microbe of the invention is referred to as B.t. PS50C. The spores or crystals of this microbe, or mutants thereof, are useful to control coleopteran pests in various environments. The novel gene of the invention can be used to transform various hosts wherein the novel toxic protein can be expressed.
    Type: Grant
    Filed: January 2, 1992
    Date of Patent: November 22, 1994
    Assignee: Mycogen Corporation
    Inventors: Luis Foncerrada, August J. Sick, Jewel M. Payne
  • Bacillus thuringiensis isolate denoted B.t. PS81GG, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
    Patent number: 5352661
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active against the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: October 4, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson
  • Bacillus thuringiensis isolates denoted B.T. PS81F, active against lepidopteran pests
    Patent number: 5336492
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe, The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 17, 1993
    Date of Patent: August 9, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
    Patent number: 5296368
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: March 22, 1994
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Process for controlling lepidopteran pests
    Patent number: 5286485
    Abstract: The subject disclosure concerns Bacillus thuringiensis strains which can be used to control lepidopteran pests. The strains were previously known to control coleopteran pests. The discovery of lepidopteran activity was totally unexpected.These B.t. strains can be formulated using standard lepidopteran formulation procedures. Means of administration are also standard.The genes encoding lepidopteran-active toxins can be isolated from the B.t. isolates and used to transform other microbes for use to control lepidopteran pests.
    Type: Grant
    Filed: September 12, 1991
    Date of Patent: February 15, 1994
    Assignee: Mycogen Corporation
    Inventors: Kendrick A. Uyeda, Luis Foncerrada, Jewel M. Payne, Kenneth E. Narva, George E. Schwab, Gregory A. Bradfisch, August J. Sick